Sort
48,018 grants matching “immunotherapy”
Drug Development for Prostate Cancer
$782,938William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$782,862James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$782,809Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2023 · HL
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$782,809Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2022 · HL
TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES
$782,709University Of Minnesota Twin Cities · R01 · FY2001 · DK
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$782,691Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2023 · CA
Role of gamma/delta T cells in Vaccine Induced Immunity
$782,578Daniel F. Hoft · Saint Louis University · R01 · FY2017 · AI
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$782,272Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$781,984Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2024 · AI
Mechanistic Core
$781,625Lloyd F Mayer · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
B cell-dependent anti-tumor immunity in ovarian cancer
$781,585Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2021 · CA
B cell-dependent anti-tumor immunity in ovarian cancer
$781,585Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2019 · CA
B cell-dependent anti-tumor immunity in ovarian cancer
$781,585Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$781,552Madhav V Dhodapkar · Emory University · U54 · FY2020 · CA
ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME
$781,497Howard Feldman · University Of California, San Diego · R01 · FY2015 · AG
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$781,408Leslie S Kean · Seattle Children'S Hospital · R01 · FY2014 · HL
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$781,350Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Role of Th17 in Severe and Recurrent C. difficile Infection
$781,166William A Petri · University Of Virginia · R01 · FY2021 · AI
Quantitative Endogenous MRI Imaging of Neuroinflammation in AD
$781,126Qing Wang · Washington University · R01 · FY2022 · AG
Reprogramming the Tumor-Immune Interface in Oral Cancer
$780,996John B Sunwoo · Stanford University · R35 · FY2020 · DE
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$780,882Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
How Does blockade of CD40/CD40L Prevent Autoimmunity?
$780,672La Jolla Inst For Allergy &Immunolgy · U19 · FY2002 · AI
Shared Resource: Comparative Medicine
$780,585Gordon Roble · Fred Hutchinson Cancer Research Center · P30 · FY2021 · CA
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients
$780,553Zhongxing Liao · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · HL
Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid Leukemia
$780,389Pietro Genovese · Boston Children'S Hospital · R01 · FY2024 · CA